Visit COVID-19 resources

[Skip to Content]

Impact of injection frequency on 5-year real-world visual acuity outcomes of aflibercept therapy for neovascular age-related macular degeneration – (Eye Journal)

7 April 2020

This news item is available to RCOphth members only, please log in below to access.

Members Login